Skip to main content

The Health Impact Fund and the Problem of Corruption in the Global Pharmaceutical Sector

  • Chapter
  • First Online:
Integrity, Transparency and Corruption in Healthcare & Research on Health, Volume I

Abstract

The goal of this chapter is to examine the Health Impact Fund, a proposal aimed at solving the problem of access to pharmaceuticals for the global poor, focusing on its potential implications vis-à-vis the problem of corruption in the pharmaceutical industry. One set of questions concerns the extent to which the Health Impact Fund can be expected to help lessen or prevent the sorts of corruption that presently plague our system of pharmaceutical development. The second set of questions concerns the extent to which the sorts of structures and processes that are set up for the Health Impact Fund—making assessments of the impact of a given medicine on global disease burden—would themselves be vulnerable to corruption.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Brody, H. (2007). Hooked: Ethics, the medical profession and the pharmaceutical industry. Lanham, Maryland: Roman and Littlefield.

    Google Scholar 

  • Crombie, J. (2020). Medical ghost- and guest-writing as corrupt practices and how to prevent them. In K. T. Çalıyurt (Ed.), Integrity, transparency and corruption in healthcare & research on health (Vol. 1, pp. 141–158). Singapore: Springer.

    Google Scholar 

  • Eyal, N. (2012). Global health-impact labels. In Millim & Emanuel (Eds.), Global justice and bioethics (pp. 241–278). Oxford University Press.

    Google Scholar 

  • Hollis, A., & Pogge, T. (2008). The health impact fund: Making new medicines accessible for all (Incentives for Global Health, 2008). http://healthimpactfund.org.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fred Gifford .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gifford, F. (2020). The Health Impact Fund and the Problem of Corruption in the Global Pharmaceutical Sector. In: Çalıyurt, K. (eds) Integrity, Transparency and Corruption in Healthcare & Research on Health, Volume I. Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application. Springer, Singapore. https://doi.org/10.1007/978-981-15-1424-1_2

Download citation

Publish with us

Policies and ethics